Skip to content

Tranexamic Acid in Trauma Surgery Tranexamic Acid in Trauma Surgery Tranexamic Acid in Trauma Surgery

Efficacy of Tranexamic Acid in Reducing Requirement of Blood Transfusion in Lower Limb Trauma Surgery: A Prospective Randomized Controlled Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04986813
Enrollment
100
Registered
2021-08-03
Start date
2017-04-01
Completion date
2018-08-31
Last updated
2021-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Extremity Fracture, Tranexamic Acid, Trauma

Keywords

Tranexamic acid, Deep Vein Thrombosis, Blood transfusion

Brief summary

This study was done to evaluate the efficacy of Tranexamic Acid (TXA) in reducing blood transfusion requirement in patients of lower limb trauma undergoing surgery.

Detailed description

This was a single centre, parallel group, prospective randomized control study. 116 patients of lower limb trauma presented between April 2017 to August 2018 at Civil Hospital Rajpura. 16 patients were excluded due to old fracture, percutaneous wire fixation or non-consenting patient. The remaining 100 patients were randomized into two groups. 50 patients were given 1 gram of TXA before surgery and 50 patients were not given TXA. Fall in Hb, requirement of blood transfusion, number of days admitted in the hospital after surgery and evidence of deep vein thrombosis were monitored.

Interventions

DRUGTranexamic acid injection

1 g of TXA in 100 ml of normal saline

OTHERNormal Saline

100 ml

Sponsors

Jaspreet Singh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

The random allocation of the patients to either group was done by one of the investigators using a random number table.

Intervention model description

This was a single centre, parallel group, prospective randomized control study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* patients suffering from lower limb trauma

Exclusion criteria

* Presence of old implant or infection at the fracture site, * Any blood coagulation disorder * Patients undergoing percutaneous wire placement procedures for fracture fixation * Polytrauma * Non-consenting patients * Psychiatric patient

Design outcomes

Primary

MeasureTime frameDescription
Requirement of number of units of blood transfusionAverage of 15 daysFrom the date of surgery till time of discharge

Secondary

MeasureTime frameDescription
Evidence of deep vein thrombosis by Wells ScoreAverage of 15 days (From the date of surgery till time of discharge)Based on Wells et al Clinical model for DVT
Change in Haemoglobin level post surgeryAverage of 15 days (From the date of surgery till time of discharge)From the date of surgery till time of discharge
Number of days admitted in the hospital after surgeryAverage of 15 days (From the date of admission till time of discharge)From the date of admission till time of discharge

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026